Pacer Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Pacer Advisors, Inc.
- $41.8 Billion
- Q3 2024
A detailed history of Pacer Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,099,378 shares of JAZZ stock, worth $268 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
2,099,378
Previous 1,820,913
15.29%
Holding current value
$268 Million
Previous $194 Million
20.4%
% of portfolio
0.56%
Previous 0.5%
Shares
15 transactions
Others Institutions Holding JAZZ
# of Institutions
503Shares Held
58.1MCall Options Held
170KPut Options Held
152K-
Black Rock Inc. New York, NY6.15MShares$785 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$780 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$319 Million0.6% of portfolio
-
State Street Corp Boston, MA2.02MShares$258 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA1.82MShares$232 Million0.03% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.01B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...